ED
STSA

Exane Derivatives’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Exane Derivatives’s Portfolio STSA Stock Details STSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,078
Closed -$15.9K – 852
2020
Q3 		$15.9K Sell
4,078
-70
-2% -$272 ﹤0.01% 430
2020
Q2 		$119K Hold
4,148
– – 0.03% 255
2020
Q1 		$89.3K Buy
+4,148
New +$89.3K 0.02% 277